Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Women's Health therapeutics Market Research Reports

Titlepublishedprice

Global Contraceptives Sales Market Report 2016

By QYResearch Group
"...... /countries, with sales, price, revenue and market share for each player in these regions, covering - The Female Health Company - Teva Pharmaceutical Industries Ltd. - Reckitt Benckiser - Pfizer - Merck -......"
28-Nov-2016$4000

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2016

By Global Markets Direct
"...... mation of the vaginal walls due to body having less estrogen. Signs and symptoms include vaginal dryness, vaginal discharge, genital itching, burning with urination, and urgency with urination, urinary tract infections and urinary incontinence. Risk ......"
16-Nov-2016$2000

Vasomotor Symptoms of Menopause-Pipeline Insights, 2016

By Delve Insight
"...... uding Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, pate......"
01-Nov-2016$1250

Vulvovaginal Candidiasis-Pipeline Insights, 2016

By Delve Insight
"...... y, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA &......"
01-Nov-2016$1250

Dysmenorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... o understand the market and pipeline status of the drugs around the Dysmenorrhea to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report p......"
01-Nov-2016$2000

Eclampsia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... rstand the market and pipeline status of the drugs around the Eclampsia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides t......"
01-Nov-2016$2000

Dysmenorrhea-Pipeline Insights, 2016

By Delve Insight
"...... ase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations detail......"
01-Nov-2016$1250

Uterine fibroids - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... he therapeutics market revenue; average cost of therapy, treatment practice and Uterine fibroids forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of ......"
01-Nov-2016$4950

Endometriosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... to understand the market and pipeline status of the drugs around the Endometriosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Repor......"
01-Nov-2016$2000

Abortion-API Insights, 2016

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Nov-2016$1250

Avail upto 50% Discount on below Publisher Reports.